PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN- A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE

May 1, 2011, 00:00
10.1016/j.jval.2011.02.533
https://www.valueinhealthjournal.com/article/S1098-3015(11)00672-3/fulltext
Title : PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN- A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00672-3&doi=10.1016/j.jval.2011.02.533
First page : A95
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1095
Categories :
Tags :
Regions :
ViH Article Tags :